Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Modavar Pharmaceuticals is a specialty pharmaceutical company based in the United States that operates as a subsidiary of Zydus Lifesciences. The company focuses on the development, manufacturing, and commercialization of high-quality generic and specialty pharmaceutical products for the U.S. market. Modavar leverages its parent company's extensive R&D and manufacturing capabilities to provide affordable healthcare solutions across various therapeutic areas. Their portfolio includes a range of oral solids and other dosage forms targeting diverse medical conditions such as hypertension and infectious diseases. By maintaining a lean and efficient operational structure, Modavar is able to respond quickly to market needs and supply chain challenges. The company is committed to ensuring patient access to essential medications through rigorous quality standards and regulatory excellence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Modavar Pharmaceuticals.